ValorQ4, 24Q1, 25Q2, 25Q3, 25Total de pasivos3.11 M2.94 M2.53 M1.82 MCapital total5.05 M7.9 M2.82 M4.91 MTotal de pasivos y patrimonio neto8.16 M10.83 M5.35 M6.73 MDeuda total————Deuda neta————
GeoVax Labs Inc
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated.